BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

IDenta Corporation Release: Breakthrough Drug Detection Kit Now Available at the Largest Drug Store Chain in USA


10/31/2012 9:47:49 AM

JERUSALEM, Oct. 31, 2012 /PRNewswire/ -- IDenta Corp. (OTC Pink: IDTA) CEO Yaacov Shoham announced the company's revolutionary drug detection kits are being sold exclusively in the largest American drug store chain outlets, since end of September 2012. Marketed under the brand name Touch&Know, the over-the-counter unit combines safety, accuracy, affordability and ease of use for the consumer. The kit, based on proven field tests used extensively by law enforcement worldwide, is based on technology which is now available to the general public for the first time ever.

"Touch&Know is the first non-biological drug testing kit offered by a US retailer," explained Shoham. "Touch&Know safely tests the substance, as opposed to the person, and provides immediate results. It is a fully non-invasive method. We are proud to have partnered with the drug store chain, the largest retail pharmacy chain in America, to make this product available to all consumers." The drug store chain operates more than 8000 outlets in all 50 US states.

Touch&Know contains two detectors: one for general screening and one for marijuana/hashish. The patented retail package is able to detect 22 different kinds of illegal drugs.

The testing kit provides immediate display of results without lab involvement, ensuring a 99% accuracy rate in results -- environmentally friendly and in a non-confrontational approach requiring no bodily fluids.

IDenta Corp. is committed to the belief that any effective anti-drug policy begins with the ability to quickly gather credible evidence. Touch&Know offers the means to do so. The detector can assist with the resolution of drug-related issues in the home, schools and businesses.

For interviews and additional information, please contact:

Ephraim Ruttner
President

Oximeter Plus, Inc.
eruttner@oximeterplus.com
www.oximeterplus.com
516 626-6226 Ext 300

Operating since 2003, IDenta Corporation (www.touchandknow.net, www.identa-corp.com) has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and consumer markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies worldwide. Additional information may be accessed at www.drugsdetector.com, and www.identa.biz.

Disclaimer:

Certain statements contained herein may be, within the meaning of the Federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors,

Contact:
Yaacov Shoham - CEO
IDenta Corp.
Mobile: +972-52-6554487
fpi@drugsdetector.com
Site: www.drugsdetector.com,
www.identa.biz, www.identa-corp.com.

SOURCE IDenta Corporation



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->